More on BNTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $100.63 |
|
|||
| Open | $100.99 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $101.66 | ||||
| Day Low | $97.88 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 248,829 | ||||
- Form 6-K BioNTech SE For: Sep 05
- New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
- Tempus AI (TEM) Announces Real World Data Collaboration with BioNTech (BNTX)
- Tempus Announces Real World Data Collaboration with BioNTech
- Form 6-K BioNTech SE For: Aug 22
- Pfizer (PFE) and BioNTech (BNTX Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
- Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
- US FDA approves updated COVID shots ahead of fall and winter
- Form 6-K BioNTech SE For: Aug 19
- BioNTech SE (BNTX) Announces Lift of Partial Clinical Hold for BNT326/YL202
Entities mentioned with BNTX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- AdCom | View Related Stories »
- Pre Market Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Options | View Related Stories »
- Show More...
